Scott Requadt is Director of ESSA Pharma Inc.. Currently has a direct ownership of 0 shares of EPIX, which is worth approximately $0. The most recent transaction as insider was on Oct 09, 2025, when has been sold 30,002 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Scott Requadt Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 09 2025
SELL
Sale (or disposition) back to the issuer
-
30,002 Reduced 100.0%
0 Common Shares
Nov 06 2023
SELL
Other acquisition or disposition
-
12,500 Reduced 29.41%
30,002 Common Shares
Oct 30 2023
SELL
Other acquisition or disposition
-
17,502 Reduced 29.17%
42,502 Common Shares

Also insider at

TALS
Talaris Therapeutics, Inc. Healthcare
SR

Scott Requadt

Director
Louisville, KY

Track Institutional and Insider Activities on EPIX

Follow ESSA Pharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EPIX shares.

Notify only if

Insider Trading

Get notified when an Essa Pharma Inc. insider buys or sells EPIX shares.

Notify only if

News

Receive news related to ESSA Pharma Inc.

Track Activities on EPIX